|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.444 EUR | -0.06% |
|
-5.95% | -27.03% |
| Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
| Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Dec 5 (Reuters) - EMA:
* EMA: EMA PUBLISHED UPDATED INFORMATION ON COVID-19 VACCINE VALNEVA, WITH AN INCREASE IN ITS APPROVED SHELF LIFE
| 1st Jan change | Capi. | |
|---|---|---|
| -27.03% | 512M | |
| +1.51% | 42.59B | |
| +8.57% | 40.65B | |
| +49.22% | 40.57B | |
| -12.36% | 26.77B | |
| +8.92% | 24.81B | |
| -25.13% | 18.17B | |
| +29.17% | 12.05B | |
| -3.12% | 11.7B | |
| +6.35% | 11.1B |
VALNEVA 
